FDA Expands Oversight of AI-Driven Medical Devices in 2026
May 22, 2026 | Sacramento, CA — MedLegalNews.com — AI medical devices are facing heightened regulatory scrutiny in 2026 as the U.S. Food and Drug Administration expands oversight of artificial intelligence-based diagnostic systems and software-driven healthcare technologies. Regulators are increasingly focused on how machine learning tools influence patient care decisions, clinical accuracy, and long-term safety […]
FDA Expands Oversight of AI-Driven Medical Devices in 2026 Read Post »










